{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:50:09Z","timestamp":1783641009365,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.jss.2017.02.070","type":"journal-article","created":{"date-parts":[[2017,3,6]],"date-time":"2017-03-06T18:34:16Z","timestamp":1488825256000},"page":"32-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Surveillance strategies in the follow-up of melanoma patients: too much or not enough?"],"prefix":"10.1016","volume":"214","author":[{"given":"James","family":"Kurtz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia M.","family":"Beasley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen","family":"Agnese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Kendra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Olencki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Terando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Harrison","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2017.02.070_bib1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1470-2045(06)70938-X","article-title":"Complete metastasectomy in patients with stage IV metastatic melanoma","volume":"7","author":"Ollila","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jss.2017.02.070_bib2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ejso.2008.04.011","article-title":"Surgery for melanoma metastases of the gastrointestinal tract: indications and results","volume":"35","author":"Sanki","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jss.2017.02.070_bib3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00001622-200403000-00013","article-title":"Role of surgery in patients with stage IV melanoma","volume":"2","author":"Wong","year":"2004","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.jss.2017.02.070_bib4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jtcvs.2006.08.065","article-title":"Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma","volume":"133","author":"Petersen","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jss.2017.02.070_bib5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1177\/107327480601300309","article-title":"Survival after surgical resection of isolated pulmonary metastases from malignant melanoma","volume":"13","author":"Andrews","year":"2006","journal-title":"Cancer Control"},{"key":"10.1016\/j.jss.2017.02.070_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jso.21903","article-title":"Does metastasectomy improve survival in patients with stage IV melanoma? A cancer registry analysis of outcomes","volume":"104","author":"Wasif","year":"2011","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jss.2017.02.070_bib7","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1002\/1097-0142(20001101)89:9<1983::AID-CNCR15>3.3.CO;2-J","article-title":"Surgical therapy for distant metastases of malignant melanoma","volume":"89","author":"Meyer","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.jss.2017.02.070_bib8","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1245\/s10434-012-2398-z","article-title":"Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)","volume":"19","author":"Howard","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2017.02.070_bib9","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2017.02.070_bib10","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa1412082","article-title":"Nivolumab in previously untreated melanoma without B-RAF mutation","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2017.02.070_bib11","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1200\/JCO.2009.26.2063","article-title":"Site and timing of first relapse in stage III melanoma patients: implications for follow-up guidelines","volume":"28","author":"Romano","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2017.02.070_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejca.2015.11.014","article-title":"Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB-III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: ulceration of primary is key determinant for IFN-sensitivity","volume":"55","author":"Eggermont","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jss.2017.02.070_bib13","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.surg.2015.12.002","article-title":"Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes","volume":"159","author":"Egger","year":"2016","journal-title":"Surgery"},{"key":"10.1016\/j.jss.2017.02.070_bib14","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1245\/s10434-008-0238-y","article-title":"Method of detection of initial recurrence of stage II\/III cutaneous melanoma: analysis of the utility of follow-up staging","volume":"16","author":"Meyers","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2017.02.070_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.bjc.6600428","article-title":"Primary staging and follow-up in melanoma patients: monocenter evaluation of methods, costs and patient survival","volume":"87","author":"Hofmann","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jss.2017.02.070_bib16","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/SLA.0b013e318256d1f5","article-title":"A multi-center prospective evaluation of the clinical utility of PET\/CT in patients with AJCC stage IIIB or IIIC extremity melanoma","volume":"256","author":"Beasley","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2017.02.070_bib17","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1245\/s10434-008-0207-5","article-title":"The role of surveillance chest X-rays in the follow-up of high-risk melanoma patients","volume":"16","author":"Morton","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2017.02.070_bib18","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1245\/s10434-016-5642-0","article-title":"Patterns and timing of initial relapse in pathologic stage II melanoma patients","volume":"24","author":"Lee","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2017.02.070_bib19","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S1470-2045(16)30122-X","article-title":"Cobimetinib combined with vemurafenib in advanced B-RAFV600-mutant melanoma (coBRIM); updated efficacy results from a randomized, double-blind, phase 3 trial","volume":"17","author":"Ascierto","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jss.2017.02.070_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jss.2017.02.070_bib21","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.1999.17.7.2105","article-title":"High-dose recombinat interleukin 2 therapy for patients with metastatic melanoma","volume":"12","author":"Atkins","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2017.02.070_bib22","doi-asserted-by":"crossref","first-page":"9001","DOI":"10.1200\/JCO.2005.01.1551","article-title":"Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology Group","volume":"23","author":"Kaufmann","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2017.02.070_bib23","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1245\/s10434-012-2701-z","article-title":"Diversity of stage III melanoma in the era of sentinel lymph node biopsy","volume":"20","author":"Egger","year":"2013","journal-title":"Ann Surg Oncol"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480417301208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480417301208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T06:40:33Z","timestamp":1568875233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480417301208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":23,"alternative-id":["S0022480417301208"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2017.02.070","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surveillance strategies in the follow-up of melanoma patients: too much or not enough?","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2017.02.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}